Top 5 obstetric studies from September 2019

A new study finds women with postpartum hemorrhage face significantly higher odds of cardiovascular disease and thromboembolism for up to 15 years after childbirth.

In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.

A new study finds that exposure to mycoestrogens during pregnancy may reduce birthweight and impair placental efficiency, with climate change expected to increase exposure risks.

Halley Crissman, MD, MPH, and Daphna Stroumsa, MD, MPH, MSC, discuss ways in which ob/gyns can provide high-quality care for transgender and nonbinary people assigned female sex at birth.

In a recent study, prenatal PFAS exposure was linked to higher adolescent blood pressure, with stronger effects in boys and children born to non-Hispanic Black mothers.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.